Chiranjeevi Sandi
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Identification of potential therapeutic targets in prostate cancer through a cross-species approach.
Identification of potential therapeutic targets in prostate cancer through a cross-species approach.
Journal: EMBO molecular medicine
Published: February 14, 2018
'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Journal: Cell death & disease
Published: January 12, 2016
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
Journal: The Journal of pathology
Published: February 27, 2015
A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
Journal: Disease models & mechanisms
Published: February 15, 2015
Identification of telomere dysfunction in Friedreich ataxia.
Journal: Molecular neurodegeneration
Published: October 31, 2014
Epigenetic-based therapies for Friedreich ataxia.
Journal: Frontiers in genetics
Published: April 01, 2014
MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.
Journal: PloS one
Published: February 27, 2014
Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus.
Journal: PloS one
Published: July 11, 2013
Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy.
Journal: Genetics research international
Published: October 03, 2012
Last Updated: 09/26/2026